STOCK TITAN

P3 Health Partners Inc. - $PIII STOCK NEWS

Welcome to our dedicated page for P3 Health Partners news (Ticker: $PIII), a resource for investors and traders seeking the latest updates and insights on P3 Health Partners stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect P3 Health Partners's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of P3 Health Partners's position in the market.

Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) will participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, Utah. The company's management will host investor meetings on February 13th and 14th, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) reaffirms guidance for 2023 and announces guidance for 2024 at J.P. Morgan’s 42nd Annual Healthcare Conference. The company expects to achieve meaningful profitability in 2024, with a robust pipeline of strategic partnerships driving growth and momentum across key performance metrics. Dr. Sherif Abdou, co-founder and CEO, and Atul Kavthekar, CFO, are scheduled to present on January 10, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.07%
Tags
none
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) to present at J.P. Morgan Healthcare Conference on January 10, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.67%
Tags
conferences
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) to participate in BTIG Digital Health Forum with Dr. Sherif Abdou, CEO and Co-founder, on November 20, 2023. The forum will include a panel discussion at 12:00 p.m. PT/3:00 p.m. ET. P3 is a patient-centered and physician-led population health management company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.54%
Tags
conferences
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) reported a 16% YTD total revenue growth, with a strong performance across markets, re-affirming 2023 guidance and providing preliminary 2024 Full-Year Adjusted EBITDA guidance of +$20 million to +$40 million. The third-quarter 2023 financial results showed a 16% increase in total revenue to $288.4 million, with a net loss of $37.3 million and an Adjusted EBITDA loss of $22.3 million. The year-to-date 2023 financial results indicated a 16% increase in total revenue to $919.5 million, with a net loss of $117.3 million and an Adjusted EBITDA loss of $41.2 million. The company is hosting a conference call and webcast on November 8, 2023, at 4:30 PM ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.11%
Tags
none
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) plans to release its financial results for third-quarter 2023 and file its Quarterly Report on Form 10-Q on November 8, 2023. The company will host an investor call and webcast at 4:30pm ET on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
P3 Health Partners Inc. will participate in the Lake Street Best Ideas Growth Conference in New York, NY on September 14th, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.08%
Tags
conferences
-
Rhea-AI Summary
P3 Health Partners Inc. to present at Wells Fargo Healthcare Conference on September 7th, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
23.4%
Tags
conferences
-
Rhea-AI Summary
P3 Health Partners Inc. announces Q2 2023 financial results with capitated revenue of $325.6M, net loss of $27.6M, and adjusted EBITDA of $0.2M. Medical margin increases by 132.1% to $50.5M.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.67%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.34%
Tags
P3 Health Partners Inc.

Nasdaq:PIII

PIII Rankings

PIII Stock Data

80.23M
40.30M
26.16%
18.22%
1.8%
Dental Laboratories
Manufacturing
Link
United States of America
CHICAGO

About PIII

p3 health partners (p3) is a patient-centered, physician-led and population health-focused healthcare company. founded and led by physicians, sherif abdou, and amir bacchus, p3 is a team of doctors, clinicians and support service professionals with a shared passion and purpose for improving the way patient care is delivered. we are on a mission to change the way healthcare is delivered. we believe that together as physicians, we can heal the system, restore purpose and meaning in day-to-day operations, and infuse care and health back into healthcare.